Finding useful compounds is rarely a single step. It starts with deciding which molecules deserve attention among thousands or millions, and ends with evidence that a shortlisted compound truly binds and what that binding looks like. We provide an integrated set of drug screening services — from computer-aided virtual screening that ranks and prioritizes a compound collection in silico, to experimental library screening that confirms and characterizes real binding at the bench. Together, these services help discovery teams focus their effort, reduce wasted screening, and turn a long list of candidates into a short set of decision-ready hits.

Screening campaigns increasingly need more than one format to be trustworthy. A computational ranking can point the way but must be confirmed; an experimental readout can flag a compound but leaves the mechanism unexplained. By covering both the in silico and the wet-lab layers with one partner, customers avoid the delays and inconsistencies of moving a project between providers, and keep the logic of the campaign intact from first rank to final characterization.

Why Screening Matters

A hit is only valuable if it is real, relevant, and arrived at efficiently. Screening is the discipline that makes a compound list manageable and a candidate list credible:

• Cost and time – narrowing a library computationally before the bench keeps expensive experimental capacity focused on the molecules most likely to matter.
• Direction – virtual screening gives a program a starting point when no active compound is yet known, or a way to re-focus a stalled series.
• Confidence – experimental screening confirms that a flagged compound genuinely interacts with the target, separating true binders from artifacts.
• Decision-ready output – combining ranking with binding measurement yields hits that can be defended to the next stage of optimization, not just noted as interesting.

A Combined Computational & Experimental Perspective

Most screening failures trace to one of two gaps, and a durable campaign addresses both rather than treating them separately:

• The in silico layer – virtual screening prioritizes a collection using the target structure or known actives, producing a ranked, rationale-backed candidate list. This is where the search is focused and where cost is saved.
• The experimental layer – library screening confirms and measures binding through functional assays, structural soaking, and label-free kinetics. This is where a prediction is turned into evidence a team can act on.

Addressing these two layers with one consistent approach keeps the campaign coherent from first rank to final characterization, instead of re-interpreting mismatched results handed across providers.

Service Areas

Which Service Fits Your Need

From Virtual to Experimental

A screening program typically moves through stages where the same partner can stay engaged:

• Define and prepare – agree the target, the question, and the compound space; curate the library and prepare the target or reference actives.
• Rank – run virtual screening to produce a focused candidate list with a rationale for each compound.
• Confirm – test the prioritized compounds experimentally to separate true binders from false positives.
• Characterize – measure affinity and kinetics, and — where useful — determine the binding pose, so the hits are ready for optimization.

How We Support Your Program

• Target and library consultation – advice on which screening format fits the question and the materials available.
• Multiple formats under one roof – computational, functional, structural, and biophysical screening run within a single workflow.
• Documented outputs – ranked candidate lists, hit tables, and binding or structural data that can enter your project record directly.
• Flexible engagement – from a single focused campaign to ongoing screening support across a program.

An Integrated Approach

Because the two areas share the same project logic and quality discipline, customers can move smoothly from in silico ranking to experimental confirmation and characterization without changing suppliers. This continuity reduces handoff errors, shortens the path from a long list to a short hit set, and keeps the rationale behind every candidate consistent from first rank to final binding measurement — turning screening from a sequence of separate purchases into a managed, end-to-end campaign.